What is AlgiSys?
Founded in 2009 by Mr. LoPresti and Dr. Roe and headquartered in Cleveland, Ohio, AlgiSys is a biotechnology company dedicated to the commercialization of its extensive algae research, accumulated over 12 years. The company's focus on algae-based solutions positions it within the burgeoning field of sustainable biotechnology and bio-based product development.
How much funding has AlgiSys raised?
AlgiSys has raised a total of $51.4M across 3 funding rounds:
Angel/Seed
$200K
Series A
$6.2M
Series B
$45M
Angel/Seed (2011): $200K, investors not publicly disclosed
Series A (2013): $6.2M, investors not publicly disclosed
Series B (2021): $45M supported by Peakstone Securities
Key Investors in AlgiSys
Peakstone Securities
Undisclosed investor participating in the funding round.
What's next for AlgiSys?
The recent major strategic investment signifies a critical growth phase for AlgiSys, likely enabling the company to scale its operations, advance its research commercialization efforts, and potentially expand its market reach. This enterprise-level backing suggests strong investor confidence in AlgiSys's long-term vision and its capacity to deliver innovative algae-derived products or technologies. Future developments may include strategic partnerships, further product development, and market penetration initiatives.
See full AlgiSys company page
